跳至主要内容
临床试验/NCT00481702
NCT00481702已完成3 期

A Prospective, Multicenter, Open-Label, Randomized, Comparative Study to Evaluate the Efficacy, Safety, and Tolerability of Ertapenem Versus Ceftriaxone/Metronidazole in the Treatment of Intra-Abdominal Infections in Adults

Merck Sharp & Dohme LLC0 个研究点目标入组 300 人开始时间: 2001年12月最近更新:
适应症
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
300
主要终点
That ertapenem is as effective as ceftriaxone/metronidazole in the treatment of an abdominal infection

研究概览

简要总结

A multicenter study to evaluate the effectiveness of ertapenem compared to ceftriaxone/metronidazole in treating certain abdominal infections that require surgery in adult patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female patients age 18 or older
  • Patient has a diagnosis of intra-abdominal infection requiring surgery as evidenced by fever, elevated while blood cell count and abdominal pain

排除标准

  • Patient has another infection, other than abdominal
  • Female patient is pregnant or planning to become pregnant

结局指标

主要结局

That ertapenem is as effective as ceftriaxone/metronidazole in the treatment of an abdominal infection

时间窗: 2 weeks after treatment

次要结局

  • That ertapenem is as effective as ceftriaxone/metronidazole in the treatment of abdominal infection(4 weeks after treatment)

研究者

申办方类型
Industry
责任方
Sponsor

相似试验